Recommendation of the President – HCU Anamix Infant, HCU Anamix Junior, HCU Cooler, HCU Express, HCU gel, HCU Lophlex, HCU Lophlex LQ

On 1 July 2025, the President of the Agency for Health Technology Assessment and Tariff System issued recommendation No. 87/2025 on the validity of granting approval for the reimbursement of the products HCU Anamix Infant, HCU Anamix Junior, HCU Cooler, HCU Express, HCU gel, HCU Lophlex, HCU Lophlex LQ for the indications: homocystinuria, S-adenosylhomocysteine hydrolase (SAHH) deficiency, methionine adenosyltransferase I/III (MAT I/III) deficiency

Publication in Public Information Bulletin (BIP) >>